Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stein

Showing results (631-640 of 673) with videos related to

Pageof 68
Sort By:
Research Square|April 10, 2026
Reframing AI for Rare Disease RecognitionWei-Qi Wei, Chao Yan, Wu-Chen Su, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 studyGunter von Minckwitz, Andreas du Bois, Marcus Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancerGunter von Minckwitz, Kathrin Schwedler, Marcus Schmidt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2020
Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast CancerC Conefrey, J L Donovan, R C Stein, et al.
Journal of Microbiology & Biology Education|May 9, 2013
Assessing student understanding of host pathogen interactions using a concept inventoryGili Marbach-Ad, Volker Briken, Najib M El-Sayed, et al.
NPJ Breast Cancer|July 9, 2021
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology studyJohn M S Bartlett, Jane Bayani, Elizabeth Kornaga, et al.
Leukemia|October 4, 2016
Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myelomaJ R Sawyer, E Tian, J D Shaughnessy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim TrialPeter S Hall, Alison Smith, Claire Hulme, et al.
Journal of Clinical Epidemiology|October 20, 2018
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluationLeila Rooshenas, Lauren J Scott, Jane M Blazeby, et al.
Physical Review Letters|November 7, 2025
Late-Time Tails in Nonlinear Evolutions of Merging Black HolesMarina De Amicis, Hannes R Rüter, Gregorio Carullo, et al.
Pageof 68

Showing results (631-640 of 673) with videos related to

Sort By:
Pageof 68
Research Square|April 10, 2026
Reframing AI for Rare Disease RecognitionWei-Qi Wei, Chao Yan, Wu-Chen Su, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 studyGunter von Minckwitz, Andreas du Bois, Marcus Schmidt, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancerGunter von Minckwitz, Kathrin Schwedler, Marcus Schmidt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 25, 2020
Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast CancerC Conefrey, J L Donovan, R C Stein, et al.
Journal of Microbiology & Biology Education|May 9, 2013
Assessing student understanding of host pathogen interactions using a concept inventoryGili Marbach-Ad, Volker Briken, Najib M El-Sayed, et al.
NPJ Breast Cancer|July 9, 2021
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology studyJohn M S Bartlett, Jane Bayani, Elizabeth Kornaga, et al.
Leukemia|October 4, 2016
Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myelomaJ R Sawyer, E Tian, J D Shaughnessy, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim TrialPeter S Hall, Alison Smith, Claire Hulme, et al.
Journal of Clinical Epidemiology|October 20, 2018
The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluationLeila Rooshenas, Lauren J Scott, Jane M Blazeby, et al.
Physical Review Letters|November 7, 2025
Late-Time Tails in Nonlinear Evolutions of Merging Black HolesMarina De Amicis, Hannes R Rüter, Gregorio Carullo, et al.
Pageof 68